Results 81 to 90 of about 779,609 (165)

Long-Term Clinical Outcomes After Switching from Remicade((R)) to Biosimilar CT-P13 in Inflammatory Bowel Disease

open access: yes, 2017
BACKGROUND: Limited data are available on long-term clinical outcomes regarding the switch from Remicade((R)) to the infliximab biosimilar CT-P13 in inflammatory bowel disease (IBD) patients.
Hoentjen, F.   +15 more
core   +1 more source

Phenotype‐guided etiologic workup in a prospective cohort of 144 adults with developmental and epileptic encephalopathy

open access: yesEpilepsia Open, Volume 11, Issue 5, Page 1635-1650, October 2026.
Abstract Objectives Adults with developmental and epileptic encephalopathies (DEEs) often enter adult neurology care without etiologic clarification because of incomplete transition from pediatric services, outdated investigations, and attenuation of childhood electro‐clinical features over time.
Giuseppe d’Orsi   +10 more
wiley   +1 more source

Exploring Lifestyle Medicine in Rheumatic and Musculoskeletal Diseases: Findings From a Modified World Café Study

open access: yesLifestyle Medicine, Volume 7, Issue 4, October 2026.
ABSTRACT Introduction Although lifestyle medicine plays a recognised role in rheumatic and musculoskeletal disease (RMD) management, understanding how it is experienced is essential for developing effective lifestyle interventions. This study aimed to explore experiences and the impact of lifestyle medicine in RMD care and identify key facilitators and
Megan Curran   +7 more
wiley   +1 more source

Exploring Women's Experiences of Work Participation During Breast Cancer Treatment: A Qualitative Study

open access: yesHealth Expectations, Volume 29, Issue 5, October 2026.
ABSTRACT Background Breast cancer and its treatments significantly affect women's daily functioning, including their ability to engage in work. While return to work has been widely studied as an outcome, less is known about how work participation is experienced and negotiated during active treatment, particularly in relation to patients’ functioning ...
Lucia Cadorin   +4 more
wiley   +1 more source

A propensity score weighted comparison of intravenous and subcutaneous infliximab as maintenance treatment in patients with inflammatory bowel disease: The CISI study

open access: yesTherapeutic Advances in Gastroenterology
Background Comparing intravenous (IV) infliximab (IFX) with subcutaneous (SC) CT-P13 in inflammatory bowel disease (IBD) may inform clinical practice, particularly in patients in stable remission receiving maintenance therapy.
Fabio Salvatore Macaluso   +10 more
doaj   +1 more source

Unveiling the Uncharted Potential of 2D Materials in Li/Na–S Batteries: A Paradigm Shift From Graphene

open access: yesAdvanced Science, Volume 13, Issue 51, 14 September 2026.
This review explores emerging 2D materials beyond graphene, including graphdiyne, phosphorene, borophene, siloxene, MBene, antimonene, and germanene for Li/Na–S batteries. It analyzes their roles as sulfur hosts, metallic anode protectors, separators, and electrolyte fillers, emphasizing polysulfide suppression, dendrite inhibition, and interfacial ...
Naveen Kumar T. R   +7 more
wiley   +1 more source

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center [PDF]

open access: yes, 2017
Background: CT-P13, the first biosimilar monoclonal antibody to infliximab (IFX), has been confirmed to be efficacious in inducing remission in inflammatory bowel diseases (IBD).
Nagy, Ferenc   +32 more
core   +2 more sources

ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS? [PDF]

open access: yesArquivos de Gastroenterologia
Inflammatory bowel diseases (IBD) currently impose an immense social and economic burden on society in terms of both direct and indirect healthcare costs. Their incurable and progressive nature results in an unavoidable lifetime expense. The introduction
Fabio Vieira TEIXEIRA   +2 more
doaj   +1 more source

Biosimilars in Pediatric IBD: Updated Considerations for Disease Management

open access: yesBiologics: Targets & Therapy, 2022
Valeria Dipasquale, Ugo Cucinotta, Claudio Romano Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood “G.
Dipasquale V, Cucinotta U, Romano C
doaj  

Clinical significance of vestibular assessment in otosclerosis [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Otosclerosis, a 1ry osteodystrophy of the otic capsule, causes stapes fixation, progressive hearing loss, and may involve the vestibular system.
Ahmed Almeciry   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy